An FDA oncology analysis of antibody-drug conjugates

Title
An FDA oncology analysis of antibody-drug conjugates
Authors
Keywords
Antibody-drug conjugates, First-in-human start dose selection, Oncology drug development
Journal
REGULATORY TOXICOLOGY AND PHARMACOLOGY
Volume 71, Issue 3, Pages 444-452
Publisher
Elsevier BV
Online
2015-02-07
DOI
10.1016/j.yrtph.2015.01.014

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now